Altenusin

CAS No. 31186-12-6

Altenusin( —— )

Catalog No. M24242 CAS No. 31186-12-6

Altenusin is a natural nonsteroidal fungal metabolite, as a novel selective agonist of FXR with an EC50 value of 3.2 ± 0.2 μM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 922 In Stock
10MG 1225 In Stock
25MG 1538 In Stock
50MG 2325 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Altenusin
  • Note
    Research use only, not for human use.
  • Brief Description
    Altenusin is a natural nonsteroidal fungal metabolite, as a novel selective agonist of FXR with an EC50 value of 3.2 ± 0.2 μM.
  • Description
    Altenusin is a natural nonsteroidal fungal metabolite, as a novel selective agonist of FXR with an EC50 value of 3.2 ± 0.2 μM.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    FXR
  • Recptor
    FXR
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    31186-12-6
  • Formula Weight
    290.27
  • Molecular Formula
    C15H14O6
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:10 mM
  • SMILES
    OC(C1=C(C(C=C(O)C(O)=C2)=C2C)C=C(OC)C=C1O)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Zheng Z, Zhao Z, Li S, et al. Altenusin, a Nonsteroidal Microbial Metabolite, Attenuates Nonalcoholic Fatty Liver Disease by Activating the Farnesoid X Receptor. Mol Pharmacol. 2017;92(4):425-436. doi:10.1124/mol.117.108829
molnova catalog
related products
  • Androsterone

    Androsterone is a metabolic product of testosterone and can activate Farnesoid X Receptor (FXR).

  • Chenodeoxycholic Aci...

    Chenodeoxycholic Acid sodium salt (CDCA sodium salt) is a bile acid in humans that activates the nuclear receptor FXR, rescues axonal degeneration of induced pluripotent stem cell-derived neurons in patients with spastic paraplegia type 5 and cerebral xanthomatosis, and can be used to study pancreatic necrosis.

  • Nidufexor

    Nidufexor (LMB763, LMB-763) is a novel potent farnesoid X receptor (FXR) agonist?for the treatment of non-alcoholic steatohepatitis (NASH) and hepatobiliary disorders.